Click Here to return To Results

 

Effect of Glatiramer Acetate on Conversion to Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndrome (PreCISe study): A Randomised, Double-Blind, Placebo-Controlled Trial Lancet 374:1503-1511, 1475, Martinelli,G.,et al, 2009 See this aricle in Pubmed Article Abstract Early treatment with glatiramer acetate is efficacious in delaying conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome and brain lesions detected by MRI.

Related Tags

(click to filter results - removes previous filter) cop 1 efficacy MRI,abnormal multiple sclerosis,conversion to clinically definite multiple sclerosis,monosymptomatic multiple sclerosis,treatment of safety treatment of neurologic disorder

Click Here to return To Results